rs765079080
Variant summary
Our verdict is Pathogenic. Variant got 10 ACMG points: 10P and 0B. PM2PP5_Very_Strong
The NM_000093.5(COL5A1):c.2701-25T>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000274 in 1,460,902 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). There are indicators that this mutation may affect the branch point..
Frequency
Consequence
NM_000093.5 intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 10 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
COL5A1 | NM_000093.5 | c.2701-25T>G | intron_variant | ENST00000371817.8 | NP_000084.3 | |||
COL5A1 | NM_001278074.1 | c.2701-25T>G | intron_variant | NP_001265003.1 | ||||
COL5A1 | XM_017014266.3 | c.2701-25T>G | intron_variant | XP_016869755.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000399 AC: 1AN: 250602Hom.: 0 AF XY: 0.00000737 AC XY: 1AN XY: 135706
GnomAD4 exome AF: 0.00000274 AC: 4AN: 1460902Hom.: 0 Cov.: 30 AF XY: 0.00000413 AC XY: 3AN XY: 726800
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Ehlers-Danlos syndrome, classic type, 1 Pathogenic:3
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 14, 2022 | For these reasons, this variant has been classified as Pathogenic. Studies have shown that this variant results in skipping of exon 33, but is expected to preserve the integrity of the reading-frame (PMID: 9683580). ClinVar contains an entry for this variant (Variation ID: 17188). This variant has been observed in individuals with Ehlers-Danlos Syndrome (PMID: 9683580). It has also been observed to segregate with disease in related individuals. This variant is present in population databases (rs765079080, gnomAD 0.0009%). This sequence change falls in intron 32 of the COL5A1 gene. It does not directly change the encoded amino acid sequence of the COL5A1 protein. RNA analysis indicates that this variant induces altered splicing and likely results in a shortened protein product. - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Aug 01, 1998 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Genetics and Molecular Pathology, SA Pathology | Dec 16, 2021 | The COL5A1 c.2701-25T>G variant is classified as a PATHOGENIC variant (PS3, PP1_strong, PP5, PM2) This variant is a single nucleotide change from a thymine to a guanine at position 2701-25 in intron 32 of the COL5A1 gene. This variant is located in an intronic branch site and has been shown to lead to exon 33 skipping in vitro (PMID: 9683580) (PS3). The variant has been reported in multiple individuals with Ehlers-Danlos syndrome (EDS), and it has been observed to segregate with EDS in two large multigenerational families (PMID: 9683580) (PP1_strong). The variant is in dbSNP (rs765079080) but is absent from population databases (PM2). The variant has been reported in ClinVar and HGMD disease databases as a pathogenic variant (PP5). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at